Table of Content

1 Study Coverage
1.1 Cell and Gene Therapy Manufacturing Quality Control Product Introduction
1.2 Global Cell and Gene Therapy Manufacturing Quality Control Outlook 2018 VS 2022 VS 2033
1.2.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size for the Year 2018-2033
1.2.2 United States Cell and Gene Therapy Manufacturing Quality Control Market Size for the Year 2018-2033
1.3 Cell and Gene Therapy Manufacturing Quality Control Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of United States Cell and Gene Therapy Manufacturing Quality Control in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Cell and Gene Therapy Manufacturing Quality Control Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.4 Cell and Gene Therapy Manufacturing Quality Control Market Dynamics
1.4.1 Cell and Gene Therapy Manufacturing Quality Control Industry Trends
1.4.2 Cell and Gene Therapy Manufacturing Quality Control Market Drivers
1.4.3 Cell and Gene Therapy Manufacturing Quality Control Market Challenges
1.4.4 Cell and Gene Therapy Manufacturing Quality Control Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Cell and Gene Therapy Manufacturing Quality Control by Type
2.1 Cell and Gene Therapy Manufacturing Quality Control Market Segment by Type
2.1.1 Sterility Testing
2.1.2 Purity Testing
2.1.3 Potency Testing
2.1.4 Identity Testing
2.1.5 Others
2.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018, 2022 & 2033)
2.3 Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2033)
2.4 United States Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018, 2022 & 2033)
2.5 United States Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2033)
3 Cell and Gene Therapy Manufacturing Quality Control by Application
3.1 Cell and Gene Therapy Manufacturing Quality Control Market Segment by Application
3.1.1 Pharmaceutical & Biotechnology Companies
3.1.2 Contract Manufacturing Organizations
3.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018, 2022 & 2033)
3.3 Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2033)
3.4 United States Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018, 2022 & 2033)
3.5 United States Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2033)
4 Global Cell and Gene Therapy Manufacturing Quality Control Competitor Landscape by Company
4.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Company
4.1.1 Global Key Companies of Cell and Gene Therapy Manufacturing Quality Control, Ranked by Revenue (2022)
4.1.2 Global Cell and Gene Therapy Manufacturing Quality Control Revenue by Player (2018-2023)
4.2 Global Cell and Gene Therapy Manufacturing Quality Control Concentration Ratio (CR)
4.2.1 Cell and Gene Therapy Manufacturing Quality Control Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Cell and Gene Therapy Manufacturing Quality Control in 2022
4.2.3 Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Cell and Gene Therapy Manufacturing Quality Control Head office and Area Served
4.4 Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Product and Application
4.5 Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Cell and Gene Therapy Manufacturing Quality Control Market Size by Company
4.7.1 Key Players of Cell and Gene Therapy Manufacturing Quality Control in United States, Ranked by Revenue (2022)
4.7.2 United States Cell and Gene Therapy Manufacturing Quality Control Revenue by Players (2021, 2022 & 2023)
5 Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region
5.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2018-2033)
5.2.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region: 2018-2023
5.2.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2024-2033)
6 Americas
6.1 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth 2018-2033
6.2 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Type
6.2.1 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023)
6.2.2 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033)
6.2.3 Americas Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
6.3 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Application
6.3.1 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023)
6.3.2 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033)
6.3.3 Americas Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
6.4 Americas Cell and Gene Therapy Manufacturing Quality Control Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth 2018-2033
7.2 EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size by Type
7.2.1 EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023)
7.2.2 EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033)
7.2.3 EMEA Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
7.3 EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size by Application
7.3.1 EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023)
7.3.2 EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033)
7.3.3 EMEA Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
7.4 EMEA Cell and Gene Therapy Manufacturing Quality Control Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth 2018-2033
8.2 China Cell and Gene Therapy Manufacturing Quality Control Market Size by Type
8.2.1 China Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023)
8.2.2 China Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033)
8.2.3 China Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
8.3 China Cell and Gene Therapy Manufacturing Quality Control Market Size by Application
8.3.1 China Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023)
8.3.2 China Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033)
8.3.3 China Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size YoY Growth 2018-2033
9.2 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Type
9.2.1 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023)
9.2.2 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033)
9.2.3 APAC Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
9.3 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Application
9.3.1 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023)
9.3.2 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033)
9.3.3 APAC Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
9.4 APAC Cell and Gene Therapy Manufacturing Quality Control Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Bio-Rad Laboratories,Inc.
10.1.1 Bio-Rad Laboratories,Inc. Company Details
10.1.2 Bio-Rad Laboratories,Inc. Business Overview
10.1.3 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Introduction
10.1.4 Bio-Rad Laboratories,Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
10.1.5 Bio-Rad Laboratories,Inc. Recent Development
10.2 QIAGEN
10.2.1 QIAGEN Company Details
10.2.2 QIAGEN Business Overview
10.2.3 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Introduction
10.2.4 QIAGEN Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
10.2.5 QIAGEN Recent Development
10.3 Charles River Laboratories International, Inc.
10.3.1 Charles River Laboratories International, Inc. Company Details
10.3.2 Charles River Laboratories International, Inc. Business Overview
10.3.3 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Introduction
10.3.4 Charles River Laboratories International, Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
10.3.5 Charles River Laboratories International, Inc. Recent Development
10.4 Lonza Group AG
10.4.1 Lonza Group AG Company Details
10.4.2 Lonza Group AG Business Overview
10.4.3 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Introduction
10.4.4 Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
10.4.5 Lonza Group AG Recent Development
10.5 Bio-Techne Corporation
10.5.1 Bio-Techne Corporation Company Details
10.5.2 Bio-Techne Corporation Business Overview
10.5.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Introduction
10.5.4 Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
10.5.5 Bio-Techne Corporation Recent Development
10.6 Merck KGaA
10.6.1 Merck KGaA Company Details
10.6.2 Merck KGaA Business Overview
10.6.3 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Introduction
10.6.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
10.6.5 Merck KGaA Recent Development
10.7 F. Hoffmann-La Roche Ltd
10.7.1 F. Hoffmann-La Roche Ltd Company Details
10.7.2 F. Hoffmann-La Roche Ltd Business Overview
10.7.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Introduction
10.7.4 F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
10.7.5 F. Hoffmann-La Roche Ltd Recent Development
10.8 Thermo Fisher Scientific, Inc.
10.8.1 Thermo Fisher Scientific, Inc. Company Details
10.8.2 Thermo Fisher Scientific, Inc. Business Overview
10.8.3 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Introduction
10.8.4 Thermo Fisher Scientific, Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
10.8.5 Thermo Fisher Scientific, Inc. Recent Development
10.9 Intertek Group Plc
10.9.1 Intertek Group Plc Company Details
10.9.2 Intertek Group Plc Business Overview
10.9.3 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Introduction
10.9.4 Intertek Group Plc Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
10.9.5 Intertek Group Plc Recent Development
10.10 Eurofins Scientific S.E.
10.10.1 Eurofins Scientific S.E. Company Details
10.10.2 Eurofins Scientific S.E. Business Overview
10.10.3 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Introduction
10.10.4 Eurofins Scientific S.E. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
10.10.5 Eurofins Scientific S.E. Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Cell and Gene Therapy Manufacturing Quality Control Market Size United States VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Cell and Gene Therapy Manufacturing Quality Control Market Trends
Table 3. Cell and Gene Therapy Manufacturing Quality Control Market Drivers
Table 4. Cell and Gene Therapy Manufacturing Quality Control Market Challenges
Table 5. Cell and Gene Therapy Manufacturing Quality Control Market Restraints
Table 6. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. United States Cell and Gene Therapy Manufacturing Quality Control Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. United States Cell and Gene Therapy Manufacturing Quality Control Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Cell and Gene Therapy Manufacturing Quality Control, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Cell and Gene Therapy Manufacturing Quality Control Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Share by Player, 2018-2023
Table 13. Global Cell and Gene Therapy Manufacturing Quality Control Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cell and Gene Therapy Manufacturing Quality Control by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Quality Control as of 2022)
Table 15. Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Headquarters and Area Served
Table 16. Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Product and Application
Table 17. Global Key Players of Cell and Gene Therapy Manufacturing Quality Control, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Cell and Gene Therapy Manufacturing Quality Control in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States Cell and Gene Therapy Manufacturing Quality Control Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. United States Cell and Gene Therapy Manufacturing Quality Control Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2024-2033) & (US$ Million)
Table 51. Bio-Rad Laboratories,Inc. Company Details
Table 52. Bio-Rad Laboratories,Inc. Business Overview
Table 53. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product
Table 54. Bio-Rad Laboratories,Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 55. Bio-Rad Laboratories,Inc. Recent Development
Table 56. QIAGEN Company Details
Table 57. QIAGEN Business Overview
Table 58. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product
Table 59. QIAGEN Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 60. QIAGEN Recent Development
Table 61. Charles River Laboratories International, Inc. Company Details
Table 62. Charles River Laboratories International, Inc. Business Overview
Table 63. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product
Table 64. Charles River Laboratories International, Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 65. Charles River Laboratories International, Inc. Recent Development
Table 66. Lonza Group AG Company Details
Table 67. Lonza Group AG Business Overview
Table 68. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product
Table 69. Lonza Group AG Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 70. Lonza Group AG Recent Development
Table 71. Bio-Techne Corporation Company Details
Table 72. Bio-Techne Corporation Business Overview
Table 73. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product
Table 74. Bio-Techne Corporation Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 75. Bio-Techne Corporation Recent Development
Table 76. Merck KGaA Company Details
Table 77. Merck KGaA Business Overview
Table 78. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product
Table 79. Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 80. Merck KGaA Recent Development
Table 81. F. Hoffmann-La Roche Ltd Company Details
Table 82. F. Hoffmann-La Roche Ltd Business Overview
Table 83. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product
Table 84. F. Hoffmann-La Roche Ltd Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 85. F. Hoffmann-La Roche Ltd Recent Development
Table 86. Thermo Fisher Scientific, Inc. Company Details
Table 87. Thermo Fisher Scientific, Inc. Business Overview
Table 88. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product
Table 89. Thermo Fisher Scientific, Inc. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 90. Thermo Fisher Scientific, Inc. Recent Development
Table 91. Intertek Group Plc Company Details
Table 92. Intertek Group Plc Business Overview
Table 93. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product
Table 94. Intertek Group Plc Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 95. Intertek Group Plc Recent Development
Table 96. Eurofins Scientific S.E. Company Details
Table 97. Eurofins Scientific S.E. Business Overview
Table 98. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product
Table 99. Eurofins Scientific S.E. Revenue in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023) & (US$ Million)
Table 100. Eurofins Scientific S.E. Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Cell and Gene Therapy Manufacturing Quality Control Product Picture
Figure 2. Global Cell and Gene Therapy Manufacturing Quality Control Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Cell and Gene Therapy Manufacturing Quality Control Market Size 2018-2033 (US$ Million)
Figure 4. United States Cell and Gene Therapy Manufacturing Quality Control Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. United States Cell and Gene Therapy Manufacturing Quality Control Market Size 2018-2033 (US$ Million)
Figure 6. United States Cell and Gene Therapy Manufacturing Quality Control Market Share in Global 2018-2033
Figure 7. Cell and Gene Therapy Manufacturing Quality Control Report Years Considered
Figure 8. Product Picture of Sterility Testing
Figure 9. Product Picture of Purity Testing
Figure 10. Product Picture of Potency Testing
Figure 11. Product Picture of Identity Testing
Figure 12. Product Picture of Others
Figure 13. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Type in 2022 & 2033
Figure 14. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2033) & (US$ Million)
Figure 15. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
Figure 16. United States Cell and Gene Therapy Manufacturing Quality Control Market Share by Type in 2022 & 2033
Figure 17. United States Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2018-2033) & (US$ Million)
Figure 18. United States Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
Figure 19. Product Picture of Pharmaceutical & Biotechnology Companies
Figure 20. Product Picture of Contract Manufacturing Organizations
Figure 21. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Application in 2022 & 2033
Figure 22. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2033) & (US$ Million)
Figure 23. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
Figure 24. United States Cell and Gene Therapy Manufacturing Quality Control Market Share by Application in 2022 & 2033
Figure 25. United States Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2018-2033) & (US$ Million)
Figure 26. United States Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
Figure 27. The Top 5 and 10 Largest Companies of Cell and Gene Therapy Manufacturing Quality Control in the World: Market Share by Cell and Gene Therapy Manufacturing Quality Control Revenue in 2022
Figure 28. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 29. Global Cell and Gene Therapy Manufacturing Quality Control Market Share by Region (2018-2033)
Figure 30. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate 2018-2033 (US$ Million)
Figure 31. Americas Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
Figure 32. Americas Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
Figure 33. United States Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Canada Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. Mexico Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 36. Brazil Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 37. EMEA Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate 2018-2033 (US$ Million)
Figure 38. EMEA Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
Figure 39. EMEA Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
Figure 40. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. Middle East Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 42. Africa Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 43. China Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate 2018-2033 (US$ Million)
Figure 44. China Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
Figure 45. China Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
Figure 46. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate 2018-2033 (US$ Million)
Figure 47. APAC Cell and Gene Therapy Manufacturing Quality Control Market Share by Type (2018-2033)
Figure 48. APAC Cell and Gene Therapy Manufacturing Quality Control Market Share by Application (2018-2033)
Figure 49. Japan Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. South Korea Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. China Taiwan Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. Southeast Asia Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. India Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 54. Bio-Rad Laboratories,Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 55. QIAGEN Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 56. Charles River Laboratories International, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 57. Lonza Group AG Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 58. Bio-Techne Corporation Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 59. Merck KGaA Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 60. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 61. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 62. Intertek Group Plc Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 63. Eurofins Scientific S.E. Revenue Growth Rate in Cell and Gene Therapy Manufacturing Quality Control Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed